Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Bullboard Posts
Comment by mtvrdonon Mar 07, 2017 10:37am
87 Views
Post# 25943475

RE:VPT is actually is 4 cents before 10 to 1 reverse split

RE:VPT is actually is 4 cents before 10 to 1 reverse split Oh yeah... for sure.   I'm sure most of the board has read all of the past news and know that the company consolidated shares in 2015.  

The process of getting through the R&D to turn a concept into a product, the process of finding a manufacturing partner,  and the expense of getting through to FDA and Health Canada approval was definitely challenging for this company.   Many biotech companies never get to this stage.  

Fortunately, for today's investors, the big initial investments of time and money are completed.   The company has a nice small and tidy share structure, have a well funded Chinese partner and are ready to shift into sales/marketing mode.    

That's why we have some of the professional investment companies out buying again this morning (seeing more anon, PI, BBS, Mackie, M Partners, etc).


Bullboard Posts